These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27836728)

  • 1. Altered gene expression profile in a mouse model of SCN8A encephalopathy.
    Sprissler RS; Wagnon JL; Bunton-Stasyshyn RK; Meisler MH; Hammer MF
    Exp Neurol; 2017 Feb; 288():134-141. PubMed ID: 27836728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of
    Ottolini M; Barker BS; Gaykema RP; Meisler MH; Patel MK
    J Neurosci; 2017 Aug; 37(32):7643-7655. PubMed ID: 28676574
    [No Abstract]   [Full Text] [Related]  

  • 3. The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.
    Baker EM; Thompson CH; Hawkins NA; Wagnon JL; Wengert ER; Patel MK; George AL; Meisler MH; Kearney JA
    Epilepsia; 2018 Jun; 59(6):1166-1176. PubMed ID: 29782051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy.
    Wagnon JL; Korn MJ; Parent R; Tarpey TA; Jones JM; Hammer MF; Murphy GG; Parent JM; Meisler MH
    Hum Mol Genet; 2015 Jan; 24(2):506-15. PubMed ID: 25227913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy.
    Thompson JA; Miralles RM; Wengert ER; Wagley PK; Yu W; Wenker IC; Patel MK
    Epilepsia Open; 2022 Jun; 7(2):280-292. PubMed ID: 34826216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.
    Wengert ER; Saga AU; Panchal PS; Barker BS; Patel MK
    Neuropharmacology; 2019 Nov; 158():107699. PubMed ID: 31278928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal hyperexcitability in a mouse model of
    Lopez-Santiago LF; Yuan Y; Wagnon JL; Hull JM; Frasier CR; O'Malley HA; Meisler MH; Isom LL
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2383-2388. PubMed ID: 28193882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCN8A encephalopathy: Research progress and prospects.
    Meisler MH; Helman G; Hammer MF; Fureman BE; Gaillard WD; Goldin AL; Hirose S; Ishii A; Kroner BL; Lossin C; Mefford HC; Parent JM; Patel M; Schreiber J; Stewart R; Whittemore V; Wilcox K; Wagnon JL; Pearl PL; Vanderver A; Scheffer IE
    Epilepsia; 2016 Jul; 57(7):1027-35. PubMed ID: 27270488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse.
    Yu W; Hill SF; Xenakis JG; Pardo-Manuel de Villena F; Wagnon JL; Meisler MH
    Epilepsia; 2020 Dec; 61(12):2847-2856. PubMed ID: 33140451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin-Positive Interneurons Contribute to Seizures in
    Wengert ER; Miralles RM; Wedgwood KCA; Wagley PK; Strohm SM; Panchal PS; Idrissi AM; Wenker IC; Thompson JA; Gaykema RP; Patel MK
    J Neurosci; 2021 Nov; 41(44):9257-9273. PubMed ID: 34544834
    [No Abstract]   [Full Text] [Related]  

  • 11. SCN8A encephalopathy: Mechanisms and models.
    Meisler MH
    Epilepsia; 2019 Dec; 60 Suppl 3(Suppl 3):S86-S91. PubMed ID: 31904118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SCN8A encephalopathy mutation p.Ile1327Val displays elevated sensitivity to the anticonvulsant phenytoin.
    Barker BS; Ottolini M; Wagnon JL; Hollander RM; Meisler MH; Patel MK
    Epilepsia; 2016 Sep; 57(9):1458-66. PubMed ID: 27375106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prominent role of forebrain excitatory neurons in SCN8A encephalopathy.
    Bunton-Stasyshyn RKA; Wagnon JL; Wengert ER; Barker BS; Faulkner A; Wagley PK; Bhatia K; Jones JM; Maniaci MR; Parent JM; Goodkin HP; Patel MK; Meisler MH
    Brain; 2019 Feb; 142(2):362-375. PubMed ID: 30601941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.
    Estacion M; O'Brien JE; Conravey A; Hammer MF; Waxman SG; Dib-Hajj SD; Meisler MH
    Neurobiol Dis; 2014 Sep; 69():117-23. PubMed ID: 24874546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenotypic spectrum of SCN8A encephalopathy.
    Larsen J; Carvill GL; Gardella E; Kluger G; Schmiedel G; Barisic N; Depienne C; Brilstra E; Mang Y; Nielsen JE; Kirkpatrick M; Goudie D; Goldman R; Jähn JA; Jepsen B; Gill D; Döcker M; Biskup S; McMahon JM; Koeleman B; Harris M; Braun K; de Kovel CG; Marini C; Specchio N; Djémié T; Weckhuysen S; Tommerup N; Troncoso M; Troncoso L; Bevot A; Wolff M; Hjalgrim H; Guerrini R; Scheffer IE; Mefford HC; Møller RS;
    Neurology; 2015 Feb; 84(5):480-9. PubMed ID: 25568300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance.
    Makinson CD; Tanaka BS; Lamar T; Goldin AL; Escayg A
    Neurobiol Dis; 2014 Aug; 68():16-25. PubMed ID: 24704313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
    Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
    J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome.
    Lenk GM; Jafar-Nejad P; Hill SF; Huffman LD; Smolen CE; Wagnon JL; Petit H; Yu W; Ziobro J; Bhatia K; Parent J; Giger RJ; Rigo F; Meisler MH
    Ann Neurol; 2020 Mar; 87(3):339-346. PubMed ID: 31943325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epilepsy Res; 2019 Dec; 158():106222. PubMed ID: 31675620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.